Lopressor (Metoprolol tartrate)

Brand Options

arrow pointer

Brand Name : Lopressor

Marketing Authorization Holder : AstraZeneca

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Metoprolol tartrate

Manufactured By : Authorized Indian and UK Generic

Prescription Required

 
 

Product Details

Lopressor

Lopressor is called Betaloc globally.

Information about Lopressor (Metoprolol Tartrate)

Lopressor is a brand name for metoprolol tartrate, a selective beta-1 adrenergic antagonist (beta-blocker) used primarily in the management of cardiovascular conditions. It helps to reduce heart rate, decrease cardiac output, and lower blood pressure.

Product Highlights

  • To lower high blood pressure.
  • To reduce chest pain associated with angina.
  • Used as part of a comprehensive treatment plan.
  • To reduce mortality in patients post-heart attack.
  • To control heart rate in certain types of irregular heartbeat.

Key Ingredient

  • Metoprolol Tartrate

Key Benefits

  • Effective in managing hypertension.
  • Helps in controlling symptoms of angina and heart failure.
  • Associated with reduced mortality in post-myocardial infarction patients.
  • Selective beta-1 action minimizes respiratory side effects compared to non-selective beta-blockers.

Direction of Use

  • Generally administered once or twice a day, regardless of meals.
  • Swallow whole; do not crush or chew tablets.
  • Frequent monitoring of blood pressure and heart rate is advised.

Safety Concerns

  • Fatigue, dizziness, depression, and gastrointestinal issues.
  • May cause bradycardia (slow heart rate), hypotension (low blood pressure), and exacerbation of asthma or COPD.
  • Caution when used with other medications affecting heart rate or blood pressure.

Avoid Lopressor (Metoprolol Tartrate) If

  • History of hypersensitivity to metoprolol or any of its components.
  • Heart rate below 45 bpm or symptomatic bradycardia.
  • Blood pressure below 100/60 mmHg.
  • When the heart is unable to pump an adequate amount of blood.
  • In patients with reactive airway disease due to potential bronchoconstriction effects.


Image Image Image Image